An analysis of data from 41 health care systems participating in the National Patient-Centered Clinical Research Network found lower use of monoclonal antibody therapies for patients who are Black, Asian or other races compared with white and non-Hispanic patients between November 2020 and August 2021, the Centers for Disease Control and Prevention reported Friday. Among all patients with positive SARS-CoV-2 test results, the overall use of mAb was infrequent, with mean monthly use at 4% or less for all racial and ethnic groups.

In other news, the CDC Friday released updated COVID-19 masking information for consumers to reflect the latest science. The update lays out the protection provided by available masks and respirators, noting that some provide better protection than others.

Related News Articles

Perspective
The many complexities of health care today continue to challenge hospital and health system governing boards to ensure that high-quality patient care is…
Blog
Black women in the U.S. experience maternal mortality rates at nearly three times that of white women, regardless of income or education level. This…
Headline
A report from the Centers for Medicare & Medicaid Services examining disparities in care based on race, ethnicity and sex shows that in 2023, clinical care…
Headline
The Department of Health and Human Services May 1 released a final rule bolstering discrimination protections for people with disabilities under Section 504 of…
Headline
Racial and ethnic health disparities persist across the United States, even in states with otherwise high-performing health systems, according to the latest…
Blog
Since 2018, Black Maternal Health Week has been a national observance from April 11–17. This annual observance was created by the Black Mamas Matter Alliance…